Regulation of PXR in drug metabolism: chemical and structural perspectives

被引:2
作者
Gee, Rebecca R. Florke [1 ,2 ]
Huber, Andrew D. [2 ,3 ]
Chen, Taosheng [2 ,3 ]
机构
[1] St Jude Childrens Res Hosp, Grad Sch Biomed Sci, Memphis, TN USA
[2] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN USA
[3] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, 262 Danny Thomas Pl,Mail Stop 1000, Memphis, TN 38105 USA
关键词
Detoxification; drug-drug interactions; drug metabolism; nuclear receptor; posttranslational modifications; pregnane X receptor; PREGNANE-X-RECEPTOR; NF-KAPPA-B; INFLAMMATORY-BOWEL-DISEASE; UGT1A1; GENE-EXPRESSION; PRIMARY CULTURED RAT; ST JOHNS WORT; NUCLEAR RECEPTORS; XENOBIOTIC RECEPTOR; ACTIVATED RECEPTOR; CROSS-TALK;
D O I
10.1080/17425255.2024.2309212
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
IntroductionPregnane X receptor (PXR) is a master xenobiotic sensor that transcriptionally controls drug metabolism and disposition pathways. PXR activation by pharmaceutical drugs, natural products, environmental toxins, etc. may decrease drug efficacy and increase drug-drug interactions and drug toxicity, indicating a therapeutic value for PXR antagonists. However, PXR's functions in physiological events, such as intestinal inflammation, indicate that PXR activators may be useful in certain disease contexts.Areas coveredWe review the reported roles of PXR in various physiological and pathological processes including drug metabolism, cancer, inflammation, energy metabolism, and endobiotic homeostasis. We then highlight specific cellular and chemical routes that modulate PXR activity and discuss the functional consequences. Databases searched and inclusive dates: PubMed, 1 January 1980 to 10 January 2024Expert opinionKnowledge of PXR's drug metabolism function has helped drug developers produce small molecules without PXR-mediated metabolic liabilities, and further understanding of PXR's cellular functions may offer drug development opportunities in multiple disease settings.
引用
收藏
页码:9 / 23
页数:15
相关论文
共 50 条
  • [31] Screening of a chemical library reveals novel PXR-activating pharmacologic compounds
    Ratajewski, Marcin
    Grzelak, Izabela
    Wisniewska, Kamila
    Ryba, Katarzyna
    Gorzkiewicz, Michal
    Walczak-Drzewiecka, Aurelia
    Hoffmann, Marcin
    Dastych, Jaroslaw
    TOXICOLOGY LETTERS, 2015, 232 (01) : 193 - 202
  • [32] Epigenetic-dependent regulation of drug transport and metabolism: an update
    Kacevska, Marina
    Ivanov, Maxim
    Ingelman-Sundberg, Magnus
    PHARMACOGENOMICS, 2012, 13 (12) : 1373 - 1385
  • [33] Aryl hydrocarbon receptor (AhR) and pregnane X receptor (PXR) play both distinct and common roles in the regulation of colon homeostasis and intestinal carcinogenesis
    Vazquez-Gomez, Gerardo
    Petras, Jiri
    Dvorak, Zdenek
    Vondracek, Jan
    BIOCHEMICAL PHARMACOLOGY, 2023, 216
  • [34] Clinical and Molecular Perspectives on Inflammation-Mediated Regulation of Drug Metabolism and Transport
    Dunvald, Ann-Cathrine Dalgard
    Jarvinen, Erkka
    Mortensen, Christina
    Stage, Tore B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 112 (02) : 277 - 290
  • [35] Developing Adnectins That Target SRC Co-Activator Binding to PXR: A Structural Approach toward Understanding Promiscuity of PXR
    Khan, Javed A.
    Camac, Daniel M.
    Low, Simon
    Tebben, Andrew J.
    Wense, David L., I
    Wright, Martin C.
    Su, Julie
    Jenny, Victoria
    Das Gupta, Ruchira
    Ruzanov, Max
    Russo, Katie A.
    Bell, Aneka
    An, Yongmi
    Bryson, James W.
    Gao, Mian
    Gambhire, Pallavi
    Baldwin, Eric T.
    Gardner, Daniel
    Cavallaro, Cullen L.
    Duncia, John V.
    Hynes, John, Jr.
    JOURNAL OF MOLECULAR BIOLOGY, 2015, 427 (04) : 924 - 942
  • [36] PXR-mediated idiosyncratic drug-induced liver injury: mechanistic insights and targeting approaches
    Wang, Jingheng
    Bwayi, Monicah
    Gee, Rebecca R. Florke
    Chen, Taosheng
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2020, 16 (08) : 711 - 722
  • [37] Interplay between cholesterol and drug metabolism
    Rezen, Tadeja
    Rozman, Damjana
    Pascussi, Jean-Marc
    Monostory, Katalin
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2011, 1814 (01): : 146 - 160
  • [38] PXR-ABC drug transporters/CYP-mediated ursolic acid transport and metabolism in vitro and vivo
    Wen, Jinhua
    Zhou, Ying
    Li, Yuhua
    ARCHIV DER PHARMAZIE, 2020, 353 (09)
  • [39] Current trends in drug metabolism and pharmacokinetics
    Li, Yuhua
    Meng, Qiang
    Yang, Mengbi
    Liu, Dongyang
    Hou, Xiangyu
    Tang, Lan
    Wang, Xin
    Lyu, Yuanfeng
    Chen, Xiaoyan
    Liu, Kexin
    Yu, Ai-Ming
    Zuo, Zhong
    Bi, Huichang
    ACTA PHARMACEUTICA SINICA B, 2019, 9 (06) : 1113 - 1144
  • [40] Xenobiotic-sensing nuclear receptors involved in drug metabolism: a structural perspective
    Wallace, Bret D.
    Redinbo, Matthew R.
    DRUG METABOLISM REVIEWS, 2013, 45 (01) : 79 - 100